MARENA FARES: Open Payments
NPI 1497264691 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 86 payments from 14 companies in 2025. Trend: 2023 $1,633 · 2024 $2,464 · 2025 $2,240
Food & beverage: $2,075Education: $165
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $433 |
| ABBVIE INC. | 21 | $356 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $271 |
| Janssen Biotech, Inc. | 14 | $236 |
| Organon LLC | 9 | $226 |
| Galderma Laboratories, L.P. | 6 | $185 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $147 |
| Janssen Scientific Affairs, LLC | 2 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
Products named: Bimzelx, SKYRIZI, TREMFYA, VTAMA, DUPIXENT, COSENTYX, NEMLUVIO, ILUMYA.
Industry payments across PA — which companies pay providers there.
